Friday – Basic Science Track 1A Survey

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
Decoding sneaky botulinum neurotoxin type A neuronal break-in into synaptic vesicles using super-resolution microscopy
Fred Meunier, PhD (Australia)
The effects of botulinum neurotoxins in the intestine in a mouse model of foodborne botulism
Ornella Rossetto, PhD (Italy)
Elongated iBoNT: A new botulinum neurotoxin construct for treatment of chronic pain
Charlotte Leese, PhD (UK)
Botulinum neurotoxin type A hijacks a heterotrimeric plasma membrane complex to intoxicate neurons
Merja Joensuu, PhD (Australia)
Botulinum neurotoxin type DC (BoNT/DC) blocks melanocyte melanogenesis
Birgitte Sondergaard, PhD (United States)
YesNo
Decoding sneaky botulinum neurotoxin type A neuronal break-in into synaptic vesicles using super-resolution microscopy
Fred Meunier, PhD (Australia)
The effects of botulinum neurotoxins in the intestine in a mouse model of foodborne botulism
Ornella Rossetto, PhD (Italy)
Elongated iBoNT: A new botulinum neurotoxin construct for treatment of chronic pain
Charlotte Leese, PhD (UK)
Botulinum neurotoxin type A hijacks a heterotrimeric plasma membrane complex to intoxicate neurons
Merja Joensuu, PhD (Australia)
Botulinum neurotoxin type DC (BoNT/DC) blocks melanocyte melanogenesis
Birgitte Sondergaard, PhD (United States)
YesNo
Decoding sneaky botulinum neurotoxin type A neuronal break-in into synaptic vesicles using super-resolution microscopy
Fred Meunier, PhD (Australia)
The effects of botulinum neurotoxins in the intestine in a mouse model of foodborne botulism
Ornella Rossetto, PhD (Italy)
Elongated iBoNT: A new botulinum neurotoxin construct for treatment of chronic pain
Charlotte Leese, PhD (UK)
Botulinum neurotoxin type A hijacks a heterotrimeric plasma membrane complex to intoxicate neurons
Merja Joensuu, PhD (Australia)
Botulinum neurotoxin type DC (BoNT/DC) blocks melanocyte melanogenesis
Birgitte Sondergaard, PhD (United States)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care